A new study published in the Journal of the European Academy of Dermatology & Venerology showed that in children with severe ...
Please provide your email address to receive an email when new articles are posted on . Percentages of patients with at least one atopic comorbidity ranged from 69.9% to 75.4%. Percentages of patients ...
Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a ...
New real-world evidence highlights lebrikizumab’s effectiveness and safety in atopic dermatitis. Discover how patients ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and ...
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab -- a novel, patient-tailored monoclonal antibody therapy -- showed promising results both while ...
SAN FRANCISCO, Feb. 10, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin ...
A 28-year-old woman presented to her primary care provider with the chief report of persistent itch associated with atopic dermatitis (AD), with itch severity worst on her hands bilaterally. AD was ...
Credit: Lilly The approval of Ebglyss, an interleukin-13 antagonist, was supported by data from 3 clinical trials. Ebglyss can be used with or without topical corticosteroids. The Food and Drug ...
What exactly is severe AD? AD is the most common type of eczema. When this eczema becomes severe, a person has patches of skin that are red, swollen, and unbearably itchy. The patches of AD can weep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback